| Carolynn Lee Vallot, LMHC | |
|
970 Hope St, Bristol, RI 02809-1224 | |
| (401) 253-0002 | |
| Not Available |
| Full Name | Carolynn Lee Vallot |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 970 Hope St, Bristol, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740440619 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | MHC00361 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carolynn Lee Vallot, LMHC 970 Hope St, Bristol, RI 02809-1224 Ph: (401) 253-0002 | Carolynn Lee Vallot, LMHC 970 Hope St, Bristol, RI 02809-1224 Ph: (401) 253-0002 |
News Archive
Parkinson's disease, a progressive nervous system disorder that affects movement, causes one of the highest risks of falling among all neurological conditions. Due to this, many patients develop a fear of falling, even if they have never fallen.
Researchers from the US and Australia recently conducted some studies to assess the in vitro antiviral and virucidal (irreversible) activity of astodrimer sodium against SARS-CoV-2.
NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that it has received $3.75 million in milestone payments from partner Galderma S.A.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
An international team, headed by researchers at the University of California, San Diego School of Medicine, has identified a key enzyme in the reprogramming process that promotes malignant stem cell cloning and the growth of chronic myeloid leukemia (CML), a cancer of the blood and marrow that experts say is increasing in prevalence.
› Verified 4 days ago
Ms. Lynn Marie Weisman, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 417 Hope St, Bristol, RI 02809 Phone: 561-445-6064 | |
Hannah Goodman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 11 Meadow Ln, Bristol, RI 02809 Phone: 401-903-2163 | |
Colleen Desmond, LICSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 10 Stephen Dr, Bristol, RI 02809 Phone: 401-662-7371 | |
Paul Castaldi, LICSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 256 Hope St, Bristol, RI 02809 Phone: 401-855-7961 | |
Claudia Deforest, MSCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5 Shore Rd, Bristol, RI 02809 Phone: 215-776-4845 | |
Carrie Sandman, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 970 Hope St, Bristol, RI 02809 Phone: 401-253-0002 Fax: 401-253-0003 | |
Marguerite Peruto, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10 Wardwell Street, Studio #4, Bristol, RI 02809 Phone: 401-297-1001 |